| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.6 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |